# Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure

> **NCT04410042** · PHASE3 · TERMINATED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 15 (actual)

## Conditions studied

- Cancer of the Bone
- Limb Salvage

## Interventions

- **DRUG:** Tranexamic Acid
- **OTHER:** 0.9% sodium chloride

## Key facts

- **NCT ID:** NCT04410042
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-01-29
- **Primary completion:** 2024-01-16
- **Final completion:** 2024-01-16
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Per sponsor
- **Last updated:** 2024-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04410042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04410042, "Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04410042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*